Press releases
- Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
- Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
- Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
- Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
More ▼
Key statistics
On Friday, Exelixis Inc (E2XE34:SAO) closed at 58.14, -3.50% below its 52-week high of 60.25, set on Apr 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 58.14 |
---|---|
High | 58.14 |
Low | 58.14 |
Bid | 58.20 |
Offer | 58.50 |
Previous close | 60.25 |
Average volume | 5.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 07 2024 20:54 BST.
More ▼